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Social phobiaSocial anxiety disorder (SAD) is a common, chronic and disabling mental disorder. Cognitive Behaviour Therapy
(CBT) is a highly effective treatment of SAD and internet CBT (iCBT) offers a cost-effective and convenient alter-
native to face to face approaches, with high ﬁdelity and demonstrated efﬁcacy. The aim of the current paper was
to evaluate the effectiveness of an iCBT programme for SAD (The ThisWay Up Clinic Shyness Programme) when
delivered in routine practice through two different pathways. Patients in the prescription pathway (Study 1, N=
368, 50% female, mean age = 34) were ‘prescribed’ the Shyness Programme by a registered practitioner of the
This Way Up Clinic who supervised their progress throughout the programme. Patients in the referral pathway
(Study 2, N=192, 50% female, mean age=36)were referred to the ThisWay Up Clinic and supervised by a spe-
cialist CBT clinician at the clinic. Intention-to-treat marginal model analyses demonstrated signiﬁcant reductions
in primary outcomes of social anxiety symptoms (Mini-SPIN) and psychological distress (K10), corresponding to
large effect sizes (Cohen's d= .82–1.09, 95% CIs .59–1.31) and secondary outcomes of impairment (WHODAS-II)
and depressive symptoms (PHQ9), corresponding to small effect sizes (Cohen's d= .36–.46, 95% CIs .19–.68) for
patients in both pathways. Results provide evidence of the effectiveness of iCBT for social anxiety disorder when
delivered in routine practice.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Social anxiety disorder (SAD), characterized by an excessive fear of
negative evaluation or judgement (American Psychiatric Association,
2013), is one of the most common mental disorders with lifetime prev-
alence rates estimated at 12.1% (Kessler et al., 2005). SAD is character-
ized by an early onset and chronic course, and is associated with
signiﬁcant distress and impairment (American Psychiatric Association,
2013).Moreover, amajority of individuals with SAD also experience co-
morbid mental health concerns such as depression, which is associated
with increased distress, impairment and risk of suicide (Ruscio et al.,
2008). Cognitive Behavioural Therapy (CBT) has shown to be highly ef-
fective in the treatment of SAD and is recommended as a ﬁrst line treat-
ment of choice in clinical guidelines (Pilling et al., 2013). Meta-analyses
of CBT for SAD report controlledmedium to large effect sizes of Cohen's
d = 0.70–0.86 (Acarturk et al., 2009; Powers et al., 2008). Althoughnxiety and Depression, Level 4,
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Williams),
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. This is an open access article undereffective treatments exist, less than half of sufferers seek treatment
(Crome et al., 2014; Gross et al., 2005; Issakidis and Andrews, 2002).
An even smaller proportion (about 24%) receives minimally adequate
treatment (Issakidis and Andrews, 2002). Access to treatment is further
reduced amongst individuals in rural areas, in individuals with low in-
come, in ethnic minorities, and in individuals over 60 years of age
(Wang et al., 2005).
One cost-effective and pragmatic means of increasing the quality of
treatment available and the reach to under-serviced populations is
through the use of internet-based cognitive behavioural therapy
(iCBT) programmes. Internet-based treatment affords many beneﬁts
over the traditional face-to-face modality, such as high ﬁdelity, greater
accessibility, convenience, and reduced cost to patients (Andersson
and Cuijpers, 2009). In addition, internet-based interventions may
have speciﬁc advantages for patients with SAD when considering the
speciﬁc fears that characterize the disorder (e.g., fear of revealing infor-
mation or interacting directlywith a therapist). Several international re-
search groups have been instrumental in the development and
evaluation of iCBT for social anxiety (Andersson et al., 2006; Berger
et al., 2009; Titov et al., 2008c) and randomized controlled trials
document the efﬁcacy of these (and similar) programmes for SAD (see
Andersson et al., 2014). In a review of 21 studies (N = 1801) of
both guided and unguided iCBT, large within-group effect sizes andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ported (Boettcher et al., 2013). Treatment gains have been maintained
when measured from 3 months to 5 years post-treatment with mean
pre-to-follow-up medium to large effect sizes (d = .64–1.67)
(Hedman et al., 2011b). Evidence also suggests that iCBT can produce
comparable effect sizes to best-practice face-to-face CBT (Andrews
et al., 2011; Hedman et al., 2011a).
The next step is to move beyond evaluations of feasibility and efﬁca-
cy to demonstrate that iCBT for SAD can be effectively delivered in
routine healthcare settings. Initial evaluation data supports the effec-
tiveness of iCBT when incorporated into routine practice (Andersson
and Hedman, 2013; Hedman et al., 2013, 2014; Mewton et al., 2012;
Newby et al., 2014; Williams and Andrews, 2013). To add to the body
of effectiveness literature, in the current studies we investigated out-
comes of our iCBT programme for SAD when delivered to patients in
routine practice via two separate pathways:when supervised by prima-
ry care practitioners in the community andwhen supervised by special-
ist clinicians.1 In both pathways, patients were treated as part of routine
clinical care and a clinical audit was conducted to determine outcomes
in these patients. In the ﬁrst pathway, patients who presented to prima-
ry care clinicians (e.g., doctor or psychologist) who were existing users
of our online service were directly prescribed the SAD iCBT course and
supervised by their primary care clinician. In the second pathway, pa-
tients were referred for assessment and treatment by their primary
care clinician, and supervised by a clinician based at our university hos-
pital clinic, where we have been using iCBT as part of routine care for
several years (see the Method section below for additional details).
We predicted signiﬁcant reductions in core symptoms of social anxiety,
psychological distress, disability and comorbid depressive symptoms
when iCBT was delivered in both treatment pathways.2. Method
2.1. Prescription and referral pathways
Patients in the prescription pathway (Study 1) were ‘prescribed’ the
Shyness Programme by a registered practitioner of the This Way Up
Clinic of the Clinical Research Unit for Anxiety and Depression
(CRUfAD). Registered practitioners included the patient's doctor
(general practitioner, psychiatrist, or primary health care physician),
psychologist, or other mental or allied health professional. Registered
practitioners were located across all of Australia. Practitioners could
prescribe the SAD iCBT course to any patient they deemedwould bene-
ﬁt from the program. The prescribing practitioner assessed the patient
and supervised them through the program. Supervision refers to reten-
tion of clinical responsibility as users of the service agree to take
responsibility for a patient and to monitor the patient's progress
throughout the program. The clinician who retains clinical responsibili-
ty is also the contact point for the patient should they have any difﬁcul-
ties as they progress through the course. Data for Study 1 were
extracted for patients with a prescription for the Shyness Programme
from September 2010 to February 2014.
Patients in the referral pathway (Study 2) were referred to the This
WayUp Clinic by either the traditional referral pathwayor the online re-
ferral pathway. In the traditional referral pathway all patients were re-
ferred for a face-to-face assessment by a senior psychiatrist at the
Anxiety Disorders Clinic (ADC) of CRUfAD. If iCBTwas deemed to be ap-
propriate for the patient (i.e., the patient was not suicidal, not suffering1 The Clinical Research Unit for Anxiety and Depression (CRUfAD), a not-for-proﬁt joint
initiative of the University of New South Wales and St. Vincent's Hospital, in Sydney,
Australia operates an internet-based clinical service known as This Way Up Clinic
(https://thiswayup.org.au/clinic/). We provide iCBT programmes for anxiety disorders
and depression for patients to access under the supervision of a registered practitioner
of the service (see Andrews and Williams, in press for details on this clinical service).from substance abuse, or psychosis) they were allocated to an ADC cli-
nician who supervised their progress throughout the programme. In
the online referral pathway, all patients were referred from registered
practitioners of the ThisWayUp Clinic to be supervised by an ADC clini-
cian. The same ADC clinicians were available for supervision of patients
from both referral pathways. The ADC clinician took clinical responsibil-
ity for the patient's progress throughout the programme. Upon comple-
tion, patients were ‘discharged’ back to the referring practitioner. Data
for Study 2 were extracted for patients with a referral for the Shyness
Programme from October 2010 to April 2014.
2.2. Ethics statement
Prior to enrolment in the programme, all individuals were informed
that data would be collected and used as per the following: “By partici-
pating in This Way Up clinic, you acknowledge that your data will be
pooled, analysed and periodically published in scientiﬁc articles to enhance
scientiﬁc knowledge in anxiety and depression. In any publication, informa-
tion will be provided in such a way that you cannot be identiﬁed”. Patients
could opt out of the use of their data for these purposes via email. All pa-
tients provided electronic informed consent that their pooleddata could
be used for these purposes.
2.3. The Shyness Programme
The core components of the Shyness Programme have been de-
scribed in detail previously (Titov et al., 2008c) and the programme
has been evaluated in a number of trials (Aydos et al., 2009; Titov
et al., 2008a,b,c). The Shyness Programmewas further developed for de-
livery in routine practice so that a patient could not advance to the sub-
sequent lesson without ﬁrst completing the preceding lesson,
downloading the associated homework components, and then waiting
for 5 days (to ensure sufﬁcient time to review materials and complete
homework tasks). All patients had 90 days to complete the programme
andwere encouraged to progress through each lesson at a pace of 1 les-
son every 1–2 weeks. Patient progress was tracked automatically
through the This Way Up Clinic software system. The programme
consisted of six online lessons representing best practice CBT as well
as regular homework assignments and access to supplementary re-
sources (e.g., assertiveness, self-esteem, conversation skills, public
speaking, and managing mood). Each lesson was designed using a car-
toon narrative and course components included: psycho-education,
graded exposure, cognitive restructuring, and relapse prevention.
In both pathways, prescribing and referring practitioners were ad-
vised that patients are unlikely to beneﬁt if they have very severe de-
pression, persistent suicidal thoughts, drug or alcohol dependence,
schizophrenia, bipolar disorder, or were taking atypical antipsychotics
or benzodiazepines. In both pathways, the supervising practitioner re-
ceived automatic updates via email regarding each patient's progress.
The supervising practitioner also received an email alert if a patient's
scores on the Kessler-10 (K10) Psychological Distress Scale indicated
elevated distress. Practitioners are encouraged to make direct contact
with the patient (preferably via telephone) in response to receiving a
high distress alert and to conduct a risk assessment if clinically
indicated.
2.4. Measures
2.4.1. Mini-Social Phobia Inventory (Mini-SPIN; Connor et al., 2001)
The Mini-SPIN is a 3-item screening measure for social anxiety that
includes questions about avoidance and fear of embarrassment. Each
item is rated using a 5-point scale, ranging from 0 (not at all) to 4 (ex-
tremely). Receiver operating characteristic analysis revealed that using
a cut-off score of 6 or greater demonstrates excellent sensitivity, speci-
ﬁcity, as well as positive and negative predictive values (Seeley-Wait
et al., 2009). The MINI-Spin correlates with change scores for other
227A.D. Williams et al. / Internet Interventions 1 (2014) 225–229validatedmeasures of social anxiety and demonstrates comparable sen-
sitivity to cognitive-behavioural treatment effects across measures,
therefore is indicated in treatment outcome studies that require mini-
mal assessment (Seeley-Wait et al., 2009).2.4.2. Kessler-10 (K10) psychological distress scale (Kessler et al., 2002)
The K10 consists of 10 items ranked on a 5-point scale designed to
measure non-speciﬁc psychological distress. The K10 is completed
prior to each lesson as a means of tracking patient distress. If a patient
endorses K10 scores in the severe range (N30), an automatic alert is
emailed to the prescribing clinician. The K10 possesses strong psycho-
metric properties (Andrews and Slade, 2001; Kessler et al., 2002;
Sunderland et al., 2012).2.4.3. World Health Organization disability assessment schedule-II
(WHODAS-II)
The WHODAS-II contains 12 items designed to measure disability
and activity limitation in the past 30 days in a variety of domains: 1) un-
derstanding and communicating, 2) self-care, 3) mobility, 4) interper-
sonal relationships, 5) work and household roles, and 6) community
roles. Each of these domains loads signiﬁcantly onto one underlying la-
tent factor of global disability (Andrews et al., 2009). The WHODAS-II
demonstrates strong psychometric properties (Federici et al., 2009).2.4.4. Patient health questionnaire (PHQ-9; (Kroenke et al., 2001))
The PHQ-9 is a self-report questionnaire corresponding to the
DSM-IV criteria for major depressive disorder. Each item is rated in fre-
quency on a 4-point scale (0 = not at all, 3 = nearly every day). Total
scores range from 0 to 27 with higher scores reﬂecting higher levels of
psychopathology. A PHQ-9 score of ≥10 is used as a clinical cut-off for
probable DSM-IV diagnosis of MDD (Zuithoff et al., 2010).2.4.5. Treatment outcomes questionnaire
Patients rated their satisfaction with the programme: Overall, how
satisﬁed are you with your treatment? (1 = very dissatisﬁed to
5 = very satisﬁed) and How conﬁdent would you be recommending the
programme to a friend with social anxiety? (1 = not at all conﬁdent to
10 = extremely conﬁdent).2 Age has been identiﬁed as a predictor of adherence in the This Way Up iCBT pro-
gramme for depression, GAD, and mixed depression and anxiety.
3 Data for the PHQ9 was available for 182 patients who commenced the Shyness Pro-
gramme after March, 2012.2.5. Statistical analyses
Intent-to-treat (ITT)marginal model analyses were used tomeasure
the change in outcome measures across time in the full sample
(including drop-outs and non-completers). This method is appropriate
for pre-post only designs (Salim et al., 2008). Effects were modelled
using the restricted maximum likelihood (REML) model estimation
method. Patientswere classiﬁed into three groups based on the number
of lessons completed. Patients who completed all six lessons are re-
ferred to as ‘completers’. Non-completers were separated into two
groups based on evidence that the treatment dose curve for our iCBT
programmes peaks at Lesson 4 (Sunderland et al., 2012), therefore pa-
tients who completed 4–5 lessons are referred to as ‘non-completers’
and patients who completed between 1 and 3 lessons are referred to
as ‘drop-outs’. Baseline data was collected at the time a patient accessed
Lesson 1 of the programme and post datawas collected at the time a pa-
tient accessed Lesson 6 of the programme.
For secondary analyses based on completion status, ANOVA and χ2
were conducted. The groups were compared on a range of variables in-
cluding: age, gender, clinician's profession, rurality (yes, no), and base-
line mean scores on the outcome measures. Conservative Cohen's d
within-group effect sizes were computed based on the following
formula: d = t*SQRT [[2(l–r)/n]]. All analyses were conducted using
SPSS version 22.3. Study 1 results: the prescription pathway
3.1. Sample characteristics
After removal of 35 patients who did not commence the programme
and 12 patients with missing baseline data, the ﬁnal sample included
368 patients (50% female) with a mean age of 33.75 years (SD =
13.39). Mean social anxiety scores on the Mini-SPIN were 8.56 (SD =
2.58) and the majority (86%, n = 317) met probable diagnostic thresh-
old criteria (MINI-SPIN ≥ 6) at intake. The profession of the prescribing
clinicianwas as follows: 38% (n=139)GP, 36% (n=132) psychologist,
18% (n=65)medical specialist, 7% (n=27) ‘other’ allied health profes-
sional, and 1% (n=5) nurse. Themajority (68%, n=249) of prescribing
clinicians were registered as practising in an urban location.
3.2. Adherence and attrition
Regarding programme adherence, 52% of patients (n = 191) com-
pleted all 6 lessons of the programme (completers), 23% (n= 84) com-
pleted 4 or 5 lessons (non-completers), and 25% (n = 93) completed
between 1 and 3 lessons (drop-outs). Programme completion (coded
as a binary outcome 0 = completed 1–5 lessons, 1 = completion of
all 6 lessons) was unrelated to a number of variables, including patient
gender, the profession of the prescriber andwhether the patient lived in
a rural area or not, all p's N .05. Programme completion did, however,
vary as a function of age, F (2, 365) = 12.92, p b .001, η2 = .06.
Bonferroni adjusted post-hoc comparisons revealed that completers
were signiﬁcantly older (M = 36.81, SD = 14.21) than non-
completers (M = 32.46, SD = 13.07) and drop-outs (M = 28.63,
SD= 9.85), p b .001. Age did not differ signiﬁcantly between the non-
completers and drop-outs, p= .15. In order to gain a better understand-
ing of variables related to treatment drop-out, patients' baseline scores
on the primary measures were also compared. There were no differ-
ences between scores on the Mini-SPIN, WHODAS-II, or PHQ9 based
on completion status, all Fs b3, all ps N .05. There was a difference for
K10 scores, F (2, 365) = 3.98, p b .05, η2 = .02. Post-hoc comparisons
indicated higher mean baseline scores in non-completers (28.44, SD=
6.74) relative to completers (26.05, SD = 7.57), p = .04. K10 scores
did not systematically differ relative to drop-outs (27.89, SD = 6.91).
These variables were also entered as predictors in amultivariate logistic
regression model predicting completion status (0 = completed b6 les-
sons, 1 = completed 6 lessons). The only signiﬁcant predictor was age
(p b .01), indicating that each additional year in age was associated
with a 1.03 increase in the likelihood of completing all 6 lessons.2
3.3. Change in outcome measures
Separate marginal model analyses with an unstructured covariance
structure were conducted in the full sample. There were main effects
of time for the Mini-SPIN, F (1, 203.27) = 229.61, p b .001, and K10
scores, F (1, 232.31)=232.31, p b .001, indicating signiﬁcant reductions
corresponding to large effect sizes (see Table 1). There were also signif-
icant main effects of time for the secondary measures of disability
(WHODAS-II), F (1, 197.84) = 115.45, p b .001 and depressive
symptoms (PHQ93), F (1, 96.72) = 60.02, p b .001, corresponding to
small effect sizes.
3.4. Treatment satisfaction
Themean score for overall treatment satisfaction (collected for com-
pleters only) was 3.86 (range 1 = 5; SD = .94). The mean rating of
Table 1
Estimated marginal means (standard errors) and within-group effect sizes (Cohen's d).
Group Lesson 1 Lesson 6
Study 1 prescription pathway M (SE) M (SE) t (df) r (for within-group ES) Effect size Cohen's d* (95% CI)
Mini-SPIN 8.56 (.13) 5.70 (.20) 15.10** (1, 204.03) .54 .99 .82–1.15
K10 26.98 (.37) 20.34 (.50) 15.11** (1, 218.16) .66 .85 .68–1.01
WHODAS 28.08 (.41) 24.22 (.50) 10.68** (1, 201.47) .81 .45 .28–.61
PHQ9 11.20 (.47) 7.86 (.54) 7.74** (1, 96.72) .77 .36 .19–.52
Study 2 referral pathway M (SE) M (SE) t (df) r (for within-group ES) Effect size Cohen's d* (95% CI)
Mini-SPIN 8.36 (.18) 5.77 (.24) 10.75** (1, 129.38) .48 1.09 .86–1.31
K10 24.83 (.51) 19.17 (.63) 10.06** (1, 129.34) .60 .82 .59–1.04
WHODAS 25.75 (.53) 22.55 (.62) 6.03** (1, 127.90) .66 .46 .23–.68
PHQ9 9.52 (.43) 7.18 (.51) 5.09** (1, 101.85) .66 .42 .13–.71
Note. Mini-SPIN = Mini Social Phobia Inventory; K10 = Kessler Distress Scale — 10 items; WHODAS = World Health Organization Disability Assessment Schedule-II; PHQ9 = Patient
Health Questionnaire−9 item; r = Pearson correlation between Lesson 1 & Lesson 6 scores; **p b .001.
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anxiety was 8.09 (range 1–10; SD= 2.03).4. Study 2 results: the referral pathway
4.1. Sample characteristics
After removal of 16 patients who did not commence the programme
and 13 patients with missing baseline data, the ﬁnal sample included
192 patients (50% female, n = 96) with a mean age of 35.58 (SD =
12.05). The mean social anxiety score on the Mini-SPIN was 8.36
(SD= 2.58) and the majority (85%, n = 163) met probable diagnostic
threshold criteria (MINI-SPIN ≥ 6) at intake. The majority of patients
(70%, n = 135) presented via the traditional referral pathway. The re-
mainder were referrals from registered This Way Up practitioners
across Australia (27%, n = 52) and from a participating health fund
(3%, n = 5). The profession of the supervising clinician was as follows:
70% (n = 135) clinical psychologist, 24% (n = 46) psychiatry registrar,
and 6% (n = 11) intern clinical psychologist. All referring clinicians
were registered as practising in an urban location.4.2. Adherence and attrition
Regarding programme adherence, 59% of patients (n = 113) com-
pleted all 6 lessons of the programme (completers), 28% (n= 54) com-
pleted 4 or 5 lessons (non-completers), and 13% (n = 25) completed
between1 and 3 lessons (drop-outs). Themeannumber of lessons com-
pleted was 5.12 (SD= 1.30). Programme completion was unrelated to
patient gender, χ2 (1) = .19, p N .05 and the profession of the supervis-
ing clinician, χ2 (3) = 1.81, p N .05. Contrary to the results in Study 1,
programme completion did not vary as a function of age, F (2, 189) =
.22 p N .05. There were also no differences in baseline scores on the
Mini-SPIN, K10, or WHODAS-II based on completion status, all Fs b2,
all ps N .05.4.3. Change in outcome measures
Separate marginal model analyses with an unstructured covari-
ance structure were conducted in the full sample. There were main
effects of time for the Mini-SPIN, F (1, 129.38) = 115.66, p b .001,
and K10 scores, F (1, 129.34) = 101.37, p b .001, indicating signiﬁ-
cant reductions corresponding to large effects sizes (see Table 1).
There were also main effects of time for the secondary measures
of disability (WHODAS-II), F (1, 127.90) = 36.42, p b .001, and
depressive symptoms (PHQ9), F (1, 101.85) = 25.91, p b .001,
corresponding to small effect sizes.4.4. Treatment satisfaction
The mean score for overall treatment satisfaction was 3.99 (range
1–5; SD = .75) and for conﬁdence in recommending the programme
to a friend with social anxiety was 8.35 (range 1–10; SD= 1.79).5. Discussion and conclusions
The current study provides evidence of the effectiveness of an
internet-based CBT (iCBT) programme for Social Anxiety Disorder
when delivered in routine practice via two separate care pathways.
Intention-to-treat analyses demonstrated that the Shyness Programme
is effective in reducing social anxiety symptoms, distress, impairment,
and depressive symptomswhen delivered in routine practice. Symptom
reduction corresponded to small to large effect sizes, irrespective of
whether clinical guidance was provided by general practitioners or
specialty-trained CBT clinicians. These results complement initial
ﬁndings of the transferability of iCBT effects from controlled trials and
provide encouraging support for the integration of iCBT for social anxi-
ety in routine care. Programme adherence in the current investigation
(52% in the prescription pathway; 59% in the referral pathway) was
consistent with average completion rates for our depression — 55%
(Williams and Andrews, 2013), GAD — 55% (Mewton et al., 2012) and
transdiagnostic— 47% (Newby et al., 2014) iCBT programmeswhen de-
livered in routine care. Although this rate aligns with median comple-
tion rates (56%) reported in a meta-analysis of computerised CBT
(Waller and Gilbody, 2010), identifying moderators of adherence
should be a focus of future research in order to improve uptake of the
full treatment package. Our research group has previously demonstrat-
ed that much of the therapeutic beneﬁt (as indexed by psychological
distress — K10 scores) is achieved by completion of Lesson 4 of our
iCBT programmes (see Sunderland et al., 2012). However, as relapse
prevention is presented in the ﬁnal Lesson (and is arguably a core com-
ponent of CBT), we would encourage adherence to the full programme
to ensure exposure to all active treatment ingredients.
The current ﬁndings should be considered in light of the limitations
of the naturalistic design. Data were collected to ensure ongoing quality
assurance and therefore measures were limited to validated question-
naires that imposed minimal response burden on the patient while fa-
cilitating interpretation on the part of the supervising practitioner. The
Mini-SPINwas designed to screen for individuals with social anxiety dis-
order in primary care, psychiatric, and other medical settings where
brevity in assessment is crucial. Although brief, theMini-SPIN does dem-
onstrate sensitivity to treatment effects and correlates well with more
comprehensive social anxiety measures (Seeley-Wait et al., 2009).
Further, the Mini-SPIN has demonstrated good discriminant validity to
distinguish individuals with SAD from those without SAD, covering
avoidance of speaking or performing activities (Connor et al., 2001).
229A.D. Williams et al. / Internet Interventions 1 (2014) 225–229In the absence of a structured diagnostic assessment, we cannot be as-
sured that all patients met full diagnostic criteria for social anxiety dis-
order. However recent evidence from our research group suggests that
outcomes following iCBT are similar whether patients are assessed by a
specialist psychiatrist or are screened for suitability based on an auto-
mated questionnaire battery (Mason and Andrews, in press).
As data were collected in the context of routine clinical practice and
there was no comparison group, the effects of natural remission or pla-
cebo response over the programme access period (typically 3 months)
cannot be separated from response to the speciﬁc treatment. Further,
we did not assess outcomes beyond the treatment period, therefore it
is unknown whether gains were maintained over time. It is also impor-
tant to note that we did not collect information on medication use. It is
possible that a proportion of patients would have also been prescribed
medication; however clinical guidelines (e.g., NICE, 2013) only recom-
mend pharmacological interventions after non-response to recom-
mended psychological therapies. Effectiveness research is aimed at
evaluating the feasibility, acceptability, and effectiveness of treatments
in environments where most patients will be treated (Roy-Byrne
et al., 2003). We are conﬁdent that the current results reﬂect routine
practice of one form of iCBT delivery currently operating in Australia.
Future research should explore the feasibility of delivering iCBT in a
range of health care settings to maximize uptake by individuals who
may be particularly resistant to traditional treatment options.
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